TORRENT PHARMACEUTICALS
Back to All Ratios
|
TORRENT PHARMACEUTICALS Last 5 Year Price to Cash Earnings (PCE) History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| PCE(x) | 43.86 | 40.45 | 35.72 | 26.66 | 32.88 |
What is the latest Price to Cash Earnings (PCE) ratio of TORRENT PHARMACEUTICALS ?
| Year | Price to Cash Earnings (PCE) |
|---|---|
| Mar2026 | 43.86 |
| Mar2025 | 40.45 |
| Mar2024 | 35.72 |
| Mar2023 | 26.66 |
| Mar2022 | 32.88 |
How is Price to Cash Earnings (PCE) of TORRENT PHARMACEUTICALS Trending?
| Years | Price to Cash Earnings (PCE) | % Change | |
|---|---|---|---|
| Mar2026 | 43.86 | 8.43 | |
| Mar2025 | 40.45 | 13.24 | |
| Mar2024 | 35.72 | 33.98 | |
| Mar2023 | 26.66 | -18.92 | |
| Mar2022 | 32.88 | - | |
Other Financial Ratios of TORRENT PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Price to Cash Earnings (PCE) ratio of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹151,078.7 Cr | 0.8% | 2.3% | 43.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,036.0 Cr | 1.5% | -3% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,218.0 Cr | -2.2% | -4.5% | 0.1% | Stock Analytics | |
| CIPLA | ₹110,897.0 Cr | 0.4% | -4% | -7.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,591.0 Cr | 0.8% | -1.8% | -3.4% | Stock Analytics | |
| MANKIND PHARMA | ₹97,332.8 Cr | -0.4% | -3.3% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 0.8% |
2.3% |
43.9% |
| SENSEX | 3.9% |
1.9% |
-6.8% |
You may also like the below Video Courses